These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25137080)

  • 1. Breast cancer risk assessment in primary care.
    Brown SL; Kartoz C
    MCN Am J Matern Child Nurs; 2014; 39(5):313-8. PubMed ID: 25137080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on breast cancer screening and prevention.
    de la Cruz MS; Sarfaty M; Wender RC
    Prim Care; 2014 Jun; 41(2):283-306. PubMed ID: 24830609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Risk Assessment: A Step-Wise Approach for Primary Care Providers on the Front Lines of Shared Decision Making.
    McClintock AH; Golob AL; Laya MB
    Mayo Clin Proc; 2020 Jun; 95(6):1268-1275. PubMed ID: 32498779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging, risk assessment and screening of breast cancer.
    Yalcin B
    Exp Oncol; 2013 Dec; 35(4):238-45. PubMed ID: 24382431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of women at high risk for breast cancer.
    Narod SA
    Prev Med; 2011 Sep; 53(3):127-30. PubMed ID: 21745498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer statistics, 2011.
    DeSantis C; Siegel R; Bandi P; Jemal A
    CA Cancer J Clin; 2011; 61(6):409-18. PubMed ID: 21969133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Analysis between the Gail, Tyrer-Cuzick and BRCAPRO Models for Breast Cancer Screening in Brazilian Population.
    Stevanato KP; Pedroso RB; Iora P; Santos LD; Pelloso FC; Melo WA; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3407-3413. PubMed ID: 31759366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Women at High Risk for Breast Cancer.
    Yogendran L; Meis L; Burnside E; Schrager S
    J Am Board Fam Med; 2024 Jan; 36(6):1029-1032. PubMed ID: 37857439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk elements and nurse practitioners' knowledge, use, and perceived comfort level of breast cancer risk assessment.
    Edwards QT; Maradiegue A; Seibert D; Saunders-Goldson S; Humphreys S
    J Am Acad Nurse Pract; 2009 May; 21(5):270-7. PubMed ID: 19432911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Breast Cancer Risk Model Estimates Among Women in Their 40s Seen in Primary Care.
    Schonberg MA; Karamourtopoulos M; Pinheiro A; Davis RB; Sternberg SB; Mehta TS; Gilliam EA; Tung NM
    J Womens Health (Larchmt); 2022 Apr; 31(4):495-502. PubMed ID: 35073183
    [No Abstract]   [Full Text] [Related]  

  • 15. Perceived risk of breast cancer among women at average and increased risk.
    Haas JS; Kaplan CP; Des Jarlais G; Gildengoin V; Pérez-Stable EJ; Kerlikowske K
    J Womens Health (Larchmt); 2005 Nov; 14(9):845-51. PubMed ID: 16313212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in breast imaging.
    Cole CF
    Lippincotts Prim Care Pract; 1998; 2(2):141-8. PubMed ID: 9727110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Organized breast cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):369-86. PubMed ID: 26263710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.
    Rogulski L; Bińczyk J
    Ginekol Pol; 2013 Sep; 84(9):754-7. PubMed ID: 24191512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast imaging and intervention in the overweight and obese patient.
    Destounis S; Newell M; Pinsky R
    AJR Am J Roentgenol; 2011 Feb; 196(2):296-302. PubMed ID: 21257879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
    Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
    J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.